Lipella Pharmaceuticals Inc.
Q2 2024 13F Holders
Symbol
LIPO
CUSIP
53630L100
Type
Equity
Class
COMMON STOCK
Num filings
8
Total reported value, excl. options
$284 k
Compare 2024 Q2 to
2024 Q3
2024 Q1
2023 Q4
2023 Q3
2023 Q2
2023 Q1
2022 Q4
Manager
Report Date
Value ($000)
Shares
Option Type